Shares of Provention Bio soared Monday after the biopharmaceutical company agreed to be acquired by France’s Sanofi (SNY) for $25 a share, or about $2.9 billion. Provention Bio (ticker: PRVB), which f...
Tag: Sanofi
Sanofi to buy Provention Bio in deal worth $2.9 billion
French pharmaceutical group Sanofi said Monday that it will buy Provention Bio, Inc., a U.S.-based biopharmaceutical company focused on autoimmune diseases, for $25 per share in cash, in a deal with a...
LLY Stock Dives — Taking Novo, Sanofi With It — After Fake Twitter Account Promises Free Insulin
Elon Musk’s new pay-for-play verification system on Twitter shook pharmaceutical mainstay Eli Lilly (LLY) — leading LLY stock to skid Friday — after a fake account claimed “insulin is free...
Pharmaceutical Stocks GSK, Sanofi, Haleon Lose Billions As Zantac Recall Trial Looms
Pharmaceutical stocks GSK (GSK), Sanofi (SNY) and Haleon (HLN) have wiped out a combined $31 billion in market cap this week as worries mount surrounding litigation around recalled heartburn drug Zant...
A New Covid Vaccine That’s Effective Against Omicron Could Hit The Market This Year
Topline Sanofi and GlaxoSmithKline are hoping to launch their latest Covid vaccine later this year after trials found it to be particularly effective against the omicron variant, promising news for th...
Covid-19 Vaccine Makers Face a New Rival as GlaxoSmithKline and Sanofi Prepare to Enter the Ring
As new Covid-19 cases fall, the postpandemic vaccine market grows more interesting. On Wednesday, GlaxoSmithKline and Sanofi, two of the world’s largest vaccine makers, said they would submit a Covid ...
Moderna Shipped 800 Million Covid-19 Vaccine Doses in 2021
Text size Syringes with Moderna’s Covid-19 vaccine. Thomas Lohnes/Getty Images Moderna said in a letter to shareholders on Tuesday that it had shipped approximately 800 million doses of its Covi...
Moderna Faces Challenges Beyond the Covid Vaccine. Its Stock Is Still a Buy for the Long Term.
In 2019, four pharmaceutical giants shared virtually all of the $33 billion worth of vaccine revenue earned worldwide. The pandemic has upended the vaccine business. Moderna has sold or contracted to ...